Stock ELVN ENLIVEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Enliven Therapeutics, Inc.

Equities

ELVN

US29337E1029

Real-time Estimate Cboe BZX
Other stock markets
 01:21:40 21/06/2024 am IST 		5-day change 1st Jan Change
21.1 USD +3.10% Intraday chart for Enliven Therapeutics, Inc. -4.09% +52.60%
11/06 Baird Initiates Enliven Therapeutics With Outperform Rating, $32 Price Target MT
29/05 Enliven Therapeutics, Inc. Appoints Lori Kunkel to the Committee CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ENLIVEN THERAPEUTICS, INC. Stock Enliven Therapeutics, Inc.
 96Cr - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 12TCr
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 11TCr
ARGENX SE Stock argenx SE
 2.26TCr -
BIONTECH SE Stock BioNTech SE
 2.08TCr -
BEIGENE, LTD. Stock BeiGene, Ltd.
 1.63TCr -
  1. Stock Market
  2. Equities
  3. ELVN Stock
  4. Charts Enliven Therapeutics, Inc.
  5. Sector Chart